The Socio-Economic Cost of Diabetes Mellitus in Korea Using National Health Insurance Claim Data, 2017
Abstract
1. Introduction
2. Data and Methods
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Centers for Disease Control and Prevention (CDC). Prevalence of self-reported cardiovascular disease among persons aged > or =35 years with diabetes-United States, 1997–2005. MMWR Morb. Mortal. Wkly. Rep. 2007, 56, 1129–1132. [Google Scholar]
- He, W.; Goodkind, D.; Kowal, P. An Aging World; US Census Bureau: Washington, DC, USA, 2016. [Google Scholar]
- American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2007. Diabetes Care 2008, 31, 596–615. [Google Scholar] [CrossRef]
- Oh, J.Y.; Lee, H.J.; Hong, E.S.; Hong, Y.S.; Sung, Y.A.; Lee, S.H. The prevalence and incidence of diabetes in mokdong, Seoul. J. Korean Diabetes Assoc. 2003, 27, 73–83. [Google Scholar]
- Kim, Y.I.; Choi, C.S.; Kim, S.W.; Lee, J.S.; Kim, H.H.; Lee, M.S.; Lee, S.I.; Park, J.Y.; Hong, S.K.; Lee, K.U. Prevalence of diabetes mellitus and impaired glucose tolerance in Korean adults living in jungup district, South Korea. J. Korean Diabetes Assoc. 1998, 22, 363–371. [Google Scholar]
- Kim, S.G.; Yang, S.W.; Choi, S.I.; Park, S.H.; Lee, K.R.; Park, J.H.; Jang, A.S.; Seo, J.P.; Lee, S.; Nam, H.S.; et al. Prevalence of diabetes mellitus in the elderly of Namwon county, South Korea. Korean J. Med. 2001, 60, 555–566. [Google Scholar] [CrossRef]
- Baik, S.H.; Choi, K.M.; Cho, Y.J.; Kim, K.O.; Kim, D.R.; Kim, N.H.; Kim, S.G.; Shin, D.H.; Park, I.B.; Choi, D.S. Prevalence of diabetes mellitus in elderly Korean in southwest Seoul (SWS Study)—Comparision of 1997 ADA & 1985 WHO criteria in elderly Korean. J. Korean Diabetes Assoc. 2001, 25, 125–132. [Google Scholar]
- Cho, N.H. Prevalence of diabetes and management status in Korean population. Korean J. Med. 2005, 68, 1–3. [Google Scholar]
- Jeong, H.J.; Kwon, H.Y.; Han, J.T.; Kim, Y.J.; Lee, A.K. Cost-effectiveness analysis of type 2 DM screening program of national health insurance corporation. Korean J. Health Econ. Policy 2008, 14, 29–50. [Google Scholar]
- Park, S.K.; Park, M.K.; Suk, J.H.; Kim, M.K.; Kim, Y.K.; Kim, I.J.; Kang, Y.H.; Lee, K.J.; Lee, H.S.; Lee, C.W.; et al. Cause-of-Death trends for diabetes mellitus over 10 years. Korean Diabetes J. 2009, 33, 65–72. [Google Scholar] [CrossRef]
- Hogan, P.; Dall, T.; Nikolov, P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003, 26, 917–932. [Google Scholar] [PubMed]
- Dawson, K.G.; Gomes, D.; Gerstein, H.; Blanchard, J.F.; Kahler, K.H. The Economic Cost of Diabetes in Canada, 1998. Diabetes Care 2002, 25, 1303–1307. [Google Scholar] [CrossRef] [PubMed]
- Williams, R.; Van Gaal, L.; Lucioni, C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 2002, 45, S13–S17. [Google Scholar] [CrossRef] [PubMed]
- Rhee, B.D. Epidemiological characteristics of diabetes mellitus among Korean population. J. Korean Diabetes Assoc. 2003, 27, 173–179. [Google Scholar]
- Park, I.B.; Baik, S.H. Epidemiologic Characteristics of Diabetes Mellitus in Korea: Current Status of Diabetic Patients Using Korean Health Insurance Database. Korean Diabetes J. 2009, 33, 357–362. [Google Scholar] [CrossRef][Green Version]
- Drummond, M.; O'Brien, B.; Stoddart, G.; Torrence, G. Methods for the Economic Evaluation of Health Care Programmes, 3rd ed.; Oxford Medical Publications: Oxford, UK, 2006. [Google Scholar]
- Han, E.-J.; Lee, J.; Cho, E.; Kim, H. Socioeconomic Costs of Dementia Based on Utilization of Health Care and Long-Term-Care Services: A Retrospective Cohort Study. Int. J. Environ. Res. Public Health 2021, 18, 376. [Google Scholar] [CrossRef]
- Putri, W.C.; Muscatello, D.J.; Stockwell, M.S.; Newall, A.T. Economic burden of seasonal influenza in the United States. Vaccine 2018, 36, 3960–3966. [Google Scholar] [CrossRef]
- Korea Health Panel. 2017. Available online: www.khp.re.kr/english/about_01.jsp (accessed on 15 January 2018).
- Hodgson, T.A.; Meiners, M.R. Cost-of-Illness Methodology: A Guide to Current Practices and Procedures. Milbank Mem. Fund Q. Heal. Soc. 1982, 60, 429. [Google Scholar] [CrossRef]
- Rice, D.P. Cost of illness studies: What is good about them? Inj. Prev. 2000, 6, 177–179. [Google Scholar] [CrossRef]
- Tarricone, R. Cost-of-illness analysis. What room in health economics? Health Policy 2006, 77, 51–63. [Google Scholar] [CrossRef]
- Chung, Y.H.; Ko, S.J. Estimating socioeconomic costs of five major diseases. Korean J. Public Financ. 2004, 18, 77–104. [Google Scholar]
- Blaiss, M.S. Allergic rhinitis: Direct and indirect costs. Allergy Asthma Proc. 2010, 31, 375–380. [Google Scholar] [CrossRef] [PubMed]
- Segel, J. Cost of Illness Studies—A Primer. RTI International: RTI-UNC Center of Excellence in Health Promotion Economics. Available online: www.rti.org/pubs/COI_Primer.pdf (accessed on 10 June 2022).
- de Jong, M.; Oskam, M.J.; Sep, S.J.; Ozcan, B.; Rutters, F.; Sijbrands, E.J.; Elders, P.J.; Siegelaar, S.E.; DeVries, J.H.; Tack, C.J.; et al. Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: Findings from the Dutch Diabetes Pearl cohort. BMJ Open Diabetes Res. Care 2020, 8, e001365. [Google Scholar] [CrossRef] [PubMed]
- de Ritter, R.; de Jong, M.; Vos, R.C.; van der Kallen, C.J.; Sep, S.J.; Woodward, M.; Stehouwer, C.D.; Bots, M.L.; Peters, S.A. Sex differences in the risk of vascular disease associated with diabetes. Biol. Sex Differ. 2020, 11, 1. [Google Scholar] [CrossRef] [PubMed]
- Kautzky-Willer, A.; Harreiter, J.; Pacini, G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr. Rev. 2016, 37, 278–316. [Google Scholar] [CrossRef]
- International Diabetes Federation. IDF Diabetes Atlas, 7th ed.; International Diabetes Federation: Brussels, Belgium, 2015. [Google Scholar]
- Baan, C.A.; Van Baal, P.H.; Jacobs-van der Bruggen, M.A.; Verkley, H.; Poos, M.J.; Hoogenveen, R.T.; Schoemaker, C.G. Diabetes mellitus in the Netherlands: Estimate of the current disease burden and prognosis for 2025. Ned. Tijdschr. Geneeskd. 2009, 153, 1052–1058. [Google Scholar]
- Oh, S.-H.; Ku, H.; Park, K.S. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: A population-based study using administrative data. BMC Public Health 2021, 21, 548. [Google Scholar] [CrossRef]
- Charbonnel, B.; Simon, D.; Dallongeville, J.; Bureau, I.; Dejager, S.; Levy-Bachelot, L.; Gourmelen, J.; Detournay, B. Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis. PharmacoEcon. Open 2017, 2, 209–219. [Google Scholar] [CrossRef]
- Stefan, B. The cost of diabetes and diabetic care. Diabetes Res. Clin. Pract. 2001, 54, S13–S18. [Google Scholar]
- Brown, J.B.; Pedula, K.L.; Bakst, A.W. The progressive cost of complication in type 2 diabetes mellitus. Arch. Intern. Med. 1999, 159, 1873–1880. [Google Scholar] [CrossRef]
- Lee, S.J. The Prediction Model of Disease Progression of Micro and Macro-complication in Diabetes Mellitus. Ph.D. Thesis, Ajou University, Suwon, Korea, 2013. [Google Scholar]
Cost | Items | Detailed Variables |
---|---|---|
Direct health cost (DHC) | Inpatient costs | Average inpatient healthcare costs (IC) Non-Benefit rate—inpatient (NBRi) |
Outpatient costs | Average outpatient healthcare costs (OC) Non-Benefit rate—outpatient (NBRo) Outpatient Pharmaceutical costs (OPC) | |
Direct non-medical care costs (DNC) | Transportation fee | Average admission rate (AR) One-way transportation fee for an inpatient (Ti) Average outpatient visit rate (OR) One-way transportation fee for an outpatient (To) |
Caregiver costs | Average days of admission (D) Average number of outpatient visits (NO) Average wage in a day (Wd) | |
Indirect cost (IDC) | Productivity loss | Average days of admission (DP) Average number of outpatient visits (NOP) Average wage in a day (WPd) Average percentage of employment (Ey) |
Premature death cost | Average wage in a year per age group (Wy) Average retirement age (Ra) Number of deaths per age group (Da) Interest rate (r) |
Characteristics | N (Mean) | % (sd) | |
---|---|---|---|
Total number of diabetes mellitus patients | 4,157,518 | 100 | |
Gender | Male | 2,153,594 | 51.8 |
Female | 2,003,924 | 48.2 | |
Age | <60 | 2,091,232 | 50.3 |
≥60 | 2,066,286 | 49.7 | |
Type of Diabetes Mellitus 1 | Type 1 (E10) | 128,883 | 3.1 |
Type 2 (E11) | 3,720,979 | 89.5 | |
Others (E12–E14) | 307,656 | 7.4 | |
Healthcare utilization | Inpatient cohort 2 | 997,157 | 23.98 |
Outpatient cohort 2 | 3,978,115 | 95.68 | |
Inpatient days per patient, mean (SD) | 8 | 51.22 |
Cost Components | Costs | ||||||
---|---|---|---|---|---|---|---|
Female | Male | Total | |||||
Costs | Percent (%) | Cost | Percent (%) | Cost | Percent (%) | ||
Direct health cost | Inpatient costs | 174,209,574 | 12.44% | 175,354,015 | 9.28% | 349,563,589 | 10.60% |
Outpatient costs | 621,452,688 | 44.37% | 617,951,679 | 32.71% | 1,239,404,367 | 37.70% | |
Direct non-medical care costs (DNC) | Transportation fee | 18,866,214 | 1.35% | 18,846,141 | 1.00% | 37,712,355 | 1.10% |
Caregiver costs | 153,622,279 | 10.97% | 138,513,226 | 7.33% | 292,135,505 | 8.90% | |
Indirect cost (IDC) | Productivity loss | 155,261,173 | 11.09% | 217,246,713 | 11.50% | 372,507,886 | 11.30% |
Premature death cost | 277,101,768 | 19.79% | 721,422,453 | 38.18% | 998,524,221 | 30.40% | |
Total | 1,400,513,696 | 100.00% | 1,889,334,227 | 100.00% | 3,289,847,923 | 100.00% |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kim, H.; Kim, E.-J. The Socio-Economic Cost of Diabetes Mellitus in Korea Using National Health Insurance Claim Data, 2017. Healthcare 2022, 10, 1601. https://doi.org/10.3390/healthcare10091601
Kim H, Kim E-J. The Socio-Economic Cost of Diabetes Mellitus in Korea Using National Health Insurance Claim Data, 2017. Healthcare. 2022; 10(9):1601. https://doi.org/10.3390/healthcare10091601
Chicago/Turabian StyleKim, Heesun, and Eun-Jung Kim. 2022. "The Socio-Economic Cost of Diabetes Mellitus in Korea Using National Health Insurance Claim Data, 2017" Healthcare 10, no. 9: 1601. https://doi.org/10.3390/healthcare10091601
APA StyleKim, H., & Kim, E.-J. (2022). The Socio-Economic Cost of Diabetes Mellitus in Korea Using National Health Insurance Claim Data, 2017. Healthcare, 10(9), 1601. https://doi.org/10.3390/healthcare10091601